OUE Healthcare Ltd

OUE Healthcare Ltd has a basic and diluted share count of 4.44 billion shares outstanding, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the liquidity risk remains unassessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. The company reported a last actual EPS of 0.04 SGD and a last actual revenue of 31.32 million SGD, suggesting a modest revenue base and earnings performance. These figures are below the typical thresholds for high-growth healthcare firms, indicating a need for further analysis of profitability and returns. OUE Healthcare Ltd's revenue is not segmented by geographic region or business line in the available data, making it difficult to assess geographic or product concentration risk. The lack of segmental data limits the ability to evaluate exposure to specific markets or services. The company's growth trajectory is not clearly defined in the available data, with no forward-looking revenue or earnings guidance provided. The absence of a detailed outlook makes it challenging to assess the company's future performance and strategic direction. The risk assessment indicates a low dilution risk, but the liquidity risk remains unassessed. The company has not disclosed any recent events, filings, or transcripts that would provide additional insight into its operational or financial status.